Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2281 AL 2295

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease

Garbarino VR, Palavicini JP, Melendez J, Barthelemy NR, He Y, Kautz TF, Lopez-Cruzan M, Mathews JJ, Xu P, Zhang B, Saliba A, Ragi N, Sharma K, Mason D, Johnson S, Hendrix S, Craft S, Petersen RC, Espindola-Netto JM, Xue A, Tchkonia T, Kirkland JL, Salardini A, Musi N, Bateman RJ, Gonzales MM, Orr ME.

Neurotherapeutics. 2025 Jul;22(4):e00591. doi: 10.1016/j.neurot.2025.e00591. Epub 2025 Apr 23.

An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease

Guo H, Yang R, Cheng W, Li Q, Du M.

Int J Mol Sci. 2025 Feb 26;26(5):2059. doi: 10.3390/ijms26052059.

The biological diagnosis of Alzheimer's disease using blood-based biomarkers: A Canadian prospective

Kumar P, Mousavi A, Frykman H.

Clin Biochem. 2025 Oct;139:110980. doi: 10.1016/j.clinbiochem.2025.110980. Epub 2025 Jul 31.

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications

Akash A, Ahamed M, Porel P, Aran KR.

Brain Res. 2025 Nov 15;1867:149949. doi: 10.1016/j.brainres.2025.149949. Epub 2025 Sep 19.

Biomarkers in Alzheimer's disease: new frontiers with olfactory models

Maheshwari S, Singh A, Verma A.

Inflammopharmacology. 2025 May;33(5):2623-2640. doi: 10.1007/s10787-025-01705-1. Epub 2025 May 1.

Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications

Liu Y, Chen Y, Chen Z, Wan H, Wu C.

J Alzheimers Dis. 2025 Nov;108(2):487-499. doi: 10.1177/13872877251378772. Epub 2025 Sep 17.

Lifestyle factors and plasma biomarkers of Alzheimer's disease: A narrative review

Hooper C, Coley N, Delrieu J, Guyonnet S.

J Prev Alzheimers Dis. 2025 Jun;12(6):100130. doi: 10.1016/j.tjpad.2025.100130. Epub 2025 Mar 12.

Analysis and interpretation of inflammatory fluid markers in Alzheimer's disease: a roadmap for standardization

Bettcher BM, de Oliveira FF, Willette AA, Michalowska MM, Machado LS, Rajbanshi B, Borelli WV, Tansey MG, Rocha A, Suryadevara V, Hu WT.

J Neuroinflammation. 2025 Apr 15;22(1):105. doi: 10.1186/s12974-025-03432-4.

Advance and Prospect of Positron Emission Tomography in Alzheimer's disease research

Wang Y, Liao W, Wang L, Li J, Huang D, Cheng W, Tian J, Luan P.

Mol Psychiatry. 2025 Oct;30(10):4899-4909. doi: 10.1038/s41380-025-03081-2. Epub 2025 Jun 21.

Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies

Rathee S, Pandey V, Soni S, Sen D, Jain SK.

Curr Alzheimer Res. 2025;22(6):414-441. doi: 10.2174/0115672050368798250626075628.

Chronic physical activity and the prevention of Alzheimer's disease

Etnier JL, Wessinger CM, Herrera BM, Kayser KC.

Psychol Sport Exerc. 2025 Sep;80:102875. doi: 10.1016/j.psychsport.2025.102875. Epub 2025 May 13.

Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring

Petersen ME, Flores-Aguilar L, Head E, Montoliu-Gaya L, Strydom A, Pape SE, Fortea J, Ashton NJ, Udeh-Momoh C, O'Bryant SE, German D, Despa F, Mapstone M, Zetterberg H.

Alzheimers Dement. 2025 Jan;21(1):e14364. doi: 10.1002/alz.14364. Epub 2024 Nov 13.

Identifying Links between Alzheimer's Disease and Type 2 Diabetes through Proteomics

Chen TN, Orr AL, Orr AG, Vacanti NM.

J Proteome Res. 2025 Aug 1;24(8):3733-3740. doi: 10.1021/acs.jproteome.5c00404. Epub 2025 Jul 7.

Comparison of plasma p-tau217/Aβ42, p-tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease

Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown C, Tropea TF, Lee EB, Tosun D, Landau SM, Okonkwo OC, Mindt MR, Weiner MW, Irwin DJ, Wolk DA, Shaw LM; and the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Aug;21(8):e70469. doi: 10.1002/alz.70469.

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease

Qiu Y, Jacobs DM, Messer K, Salmon DP, Wellington CL, Stukas S, Revta C, Brewer JB, Léger GC, Askew B, Donahue L, Kaplita S, Coric V, Qureshi IA, Feldman HH; Alzheimer’s Disease Cooperative Study T2 Protect AD Study Group.

Alzheimers Res Ther. 2025 May 2;17(1):97. doi: 10.1186/s13195-025-01745-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias